Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yee

Showing results (461-470 of 507) with videos related to

Pageof 51
Sort By:
Molecular Genetics and Metabolism|August 12, 2022
Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis IIJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Molecular Genetics and Metabolism|July 30, 2023
Corrigendum to "Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II"Joseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Molecular Genetics and Metabolism|August 26, 2022
Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized studyJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Stem Cells (Dayton, Ohio)|December 2, 2006
Antibody targeting of stem cells to infarcted myocardiumRandall J Lee, Qizhi Fang, Pamela A Davol, et al.
Scientific Reports|May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitorsBardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Frontiers in Psychiatry|May 15, 2023
Comparison of online and in-person cognitive behavioral therapy in individuals diagnosed with major depressive disorder: a non-randomized controlled trialNazanin Alavi, Elnaz Moghimi, Callum Stephenson, et al.
JIMD Reports|February 25, 2026
Intrathecal idursulfase-IT in children younger than 3 years with neuronopathic mucopolysaccharidosis II in a single-arm, open-label, phase 2/3 substudy and extensionJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Frontiers in Psychiatry|December 21, 2023
Comparing the efficacy of electronic cognitive behavioral therapy to medication and combination therapy for generalized anxiety disorder: a quasi-experimental clinical trialCallum Stephenson, Elnaz Moghimi, Yijia Shao, et al.
Neuro-Oncology Advances|February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastomaStephen J Bagley, Jacob Till, Aseel Abdalla, et al.
Journal of Inherited Metabolic Disease|September 10, 2024
Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase-IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis IIJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Pageof 51

Showing results (461-470 of 507) with videos related to

Sort By:
Pageof 51
Molecular Genetics and Metabolism|August 12, 2022
Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis IIJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Molecular Genetics and Metabolism|July 30, 2023
Corrigendum to "Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II"Joseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Molecular Genetics and Metabolism|August 26, 2022
Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized studyJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Stem Cells (Dayton, Ohio)|December 2, 2006
Antibody targeting of stem cells to infarcted myocardiumRandall J Lee, Qizhi Fang, Pamela A Davol, et al.
Scientific Reports|May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitorsBardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Frontiers in Psychiatry|May 15, 2023
Comparison of online and in-person cognitive behavioral therapy in individuals diagnosed with major depressive disorder: a non-randomized controlled trialNazanin Alavi, Elnaz Moghimi, Callum Stephenson, et al.
JIMD Reports|February 25, 2026
Intrathecal idursulfase-IT in children younger than 3 years with neuronopathic mucopolysaccharidosis II in a single-arm, open-label, phase 2/3 substudy and extensionJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Frontiers in Psychiatry|December 21, 2023
Comparing the efficacy of electronic cognitive behavioral therapy to medication and combination therapy for generalized anxiety disorder: a quasi-experimental clinical trialCallum Stephenson, Elnaz Moghimi, Yijia Shao, et al.
Neuro-Oncology Advances|February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastomaStephen J Bagley, Jacob Till, Aseel Abdalla, et al.
Journal of Inherited Metabolic Disease|September 10, 2024
Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase-IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis IIJoseph Muenzer, Barbara K Burton, Paul Harmatz, et al.
Pageof 51